Are you Dr. Duke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-543-6420Fax+1 608-890-7127
Summary
- Dr. Elizabeth Duke, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Wisconsin. She is affiliated with Fred Hutch Cancer Center, UW Medicine/Harborview Medical Center, and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonFellowship, Infectious Disease, 2017
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2010 - 2013
Marshall University Joan C. Edwards School of MedicineClass of 2010
Certifications & Licensure
WA State Medical License 2014 - 2025
WI State Medical License 2012 - 2015
Publications & Presentations
PubMed
- 94 citationsA majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation.Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner, Sarah Palmer, Adam M. Spivak
Nature Communications. 2018-11-16 - 135 citationsMolnupiravir, an Oral Antiviral Treatment for COVID-19William A. Fischer, Joseph J. Eron, Wayne Holman, Myron S. Cohen, Lei Fang
Medrxiv. 2021-06-17 - 9 citationsCMV and HSV Pneumonia After Immunosuppressive Agents for Treatment of Cytokine Release Syndrome Due to Chimeric Antigen Receptor-modified T (CAR-T)-Cell Immunotherapy.Madeleine R. Heldman, Jimmy Ma, Jordan Gauthier, Riley A O'Hara, Andrew J. Cowan
Journal of Immunotherapy. 2021-08-09
Press Mentions
What You Need to Know About Access to COVID Antiviral Drugs and Therapeutics in King County and WAJune 13th, 2022- Can These Drugs Stop a COVID Infection in Its Tracks? Seattle Researchers Are on the Forefront of New TreatmentsJune 13th, 2022
- Merck Says It Has the First Antiviral Pill Found to Be Effective Against CovidOctober 1st, 2021
